Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
03/27/1991 | EP0419091A1 Interleukin-4 receptors |
03/27/1991 | EP0419081A2 Method for protein binding enzyme complementation assays |
03/27/1991 | EP0418979A2 Method and apparatus for producing human autologous collagen |
03/27/1991 | EP0418827A1 Vaccine against Lyme disease |
03/27/1991 | EP0418704A1 Process of separating, purifying and recovering milk proteins capable of binding iron |
03/27/1991 | EP0418696A2 Derivatives of aminoacids |
03/27/1991 | EP0418647A1 Method for purifying plasminogen activator inhibitor (PAI-2) |
03/27/1991 | EP0418626A2 Fused proteins and production thereof |
03/27/1991 | EP0418617A1 Method for preparing human osteocalcin |
03/27/1991 | EP0418590A1 Antibodies, production thereof and use |
03/27/1991 | EP0418523A1 Amylose-lysozyme hybrid, an activated sugar and processes for producing them |
03/27/1991 | EP0418316A1 Platelet-specific chimeric immunoglobulin |
03/27/1991 | EP0418283A1 Antibodies |
03/27/1991 | EP0418234A1 NUCLEIC ACID ENCODING TGF--g(b)3 AND ITS USE. |
03/27/1991 | EP0418233A1 Cysteine proteinase inhibitor |
03/27/1991 | EP0418230A1 Method for potentiating and inhibiting insulin-like growth factor activity. |
03/27/1991 | EP0209586B1 Anti-histamine antibody preparation with specificity for a 4-(2-aminoethyl)imidazolyl group attached directly to an alkylene chain and immunoassay method employing the preparation |
03/27/1991 | CN1050198A Peptidase and isomerase inhibitors |
03/27/1991 | CA2026122A1 Monoclonal antibody against an acidic fgf protein, its production and use |
03/26/1991 | WO1991004276A1 Isolated, physiologically active human thrombomodulin polypeptide |
03/26/1991 | WO1991004274A1 Method for inhibiting growth of stem cells |
03/26/1991 | US5003058 DNA coding for antigen protein of rinderpest virus |
03/26/1991 | US5003048 Solvent extraction to isolate lymphokines used as antitumor agents |
03/26/1991 | US5003045 Modified 7S legume seed storage proteins |
03/26/1991 | US5003044 Peptide inhibitors of motor neuron attachment to s-laminin |
03/26/1991 | US5003043 Peptides representing epitopic sites for the major HTLV-I envelope protein, antibodies thereto, and uses thereof |
03/26/1991 | US5002933 Hexapeptide and medicinal preparation produced from it to treat erosive and ulcerative lesions of gastrointestinal tract |
03/26/1991 | US5002931 Human Hypothalmic Growth Hormone Releasing Factor |
03/26/1991 | US5002878 Novel lymphokine, monoclonal antibody specific to the lymphokine, and their production and uses |
03/26/1991 | US5002876 Pichia pastoris culture |
03/26/1991 | US5002874 Genetically engineered eucaryotic host cells capable of expressing modified forms of eIF-2α |
03/26/1991 | US5002873 DNA sequence encoding a lymphocyte adhesion receptor for high endothelium |
03/26/1991 | US5002870 Plastin isoforms and their use |
03/26/1991 | US5002765 Cloning and expression of bacillus thuringiensis gene toxic to beetles of the order coleoptera |
03/26/1991 | CA2042399A1 Isolated physiologically active human thrombomodulin polypeptide |
03/26/1991 | CA2026049A1 Organic compounds |
03/26/1991 | CA2025960A1 Methods for modulating promoter responsible for beta amyloid precursor protein expression |
03/26/1991 | CA1282022C Method for purifying an interferon |
03/26/1991 | CA1282021C Particulates having the immunogenic power of the hbs antigen and carrying an antigenic site foreign to the epitopes carried by the hbs antigen; vectors and animal cells for the production of such particulates and compositions containing such particulates for the production of mixed vaccines |
03/26/1991 | CA1282020C Proteins for the production of bioadhesives |
03/24/1991 | WO1991004275A1 New proteins suitable for combating disease and for protecting grazing cattle from ticks |
03/24/1991 | CA2054190A1 Proteins suitable for combating disease and for protecting grazing cattle from ticks |
03/24/1991 | CA2025942A1 Antibodies against highly conserved amino acid sequences of immunogenic substances, a process for the preparation of these antibodies and the use thereof in immunoassays |
03/24/1991 | CA2025941A1 Cns-active hexapeptides with an antiamnesic effect |
03/23/1991 | WO1991004273A2 Novel peptides associated with the cd4 binding region of gp120 and their methods of use |
03/23/1991 | WO1991004269A1 Medicament comprising antamanide |
03/23/1991 | CA2066721A1 Medicament comprising antamanide |
03/23/1991 | CA2066607A1 Peptides associated with the cd4 binding region of gp120 and their methods of use |
03/23/1991 | CA2025860A1 Amino acid derivatives |
03/23/1991 | CA2025630A1 Human tryptase-like protein |
03/22/1991 | CA2025833A1 Method and apparatus for producing human autologous collagen |
03/22/1991 | CA2025822A1 Flower-inducing substances and a method for production thereof |
03/21/1991 | WO1991004045A1 Prophylaxis and therapy of acquired immunodeficiency syndrome |
03/21/1991 | WO1991003569A1 Neurotrophin-3, a novel neurotrophic factor related to nerve growth factor and brain derived neurotrophic factor |
03/21/1991 | WO1991003568A1 Brain derived neurotrophic factor |
03/21/1991 | WO1991003562A1 Immunoglobulin-binding polypeptides |
03/21/1991 | WO1991003558A1 Fragments of nucleic acids derived from an appropriate mycobacteria genome, their applications in the diagnosis of mycobateria infections and plasmides containing said fragments |
03/21/1991 | WO1991003557A1 Expression of alpha-macroglobulins |
03/21/1991 | WO1991003556A1 Recombinant product |
03/21/1991 | WO1991003554A1 Cells transfected with nucleic acid encoding gtp |
03/21/1991 | WO1991003553A1 TUMOR NECROSIS FACTOR-α AND -β RECEPTORS |
03/21/1991 | WO1991003552A1 Recombinant negative strand rna virus expression systems and vaccines |
03/21/1991 | WO1991003550A1 Fusion proteins, their preparation and use |
03/21/1991 | WO1991003490A1 Polypeptide, production thereof, and pharmaceutical composition and cosmetic containing said polypeptide |
03/21/1991 | WO1991003486A1 Method for recovering recombinant proteins using flocculating agents |
03/21/1991 | WO1991003257A1 Methods for activating polymeric carriers and compositions prepared therefrom for use in affinity chromatography |
03/21/1991 | WO1991003255A1 Polypeptide vaccines against foot-and-mouth disease virus |
03/21/1991 | WO1991003254A1 Wound healing |
03/21/1991 | WO1991003252A1 Inhibition of lymphocyte adherence to vascular endothelium utilizing a novel extracellular matrix receptor-ligand interaction |
03/21/1991 | WO1991003251A1 Cr2 ligand compositions and methods for modulating immune cell functions |
03/21/1991 | WO1991002080A3 Monoclonal antibody to acetylated lysine residues in recombinant bovine somatotropin |
03/21/1991 | CA2485553A1 Tumor necrosis factor - .alpha. and - .beta. receptors |
03/21/1991 | CA2065402A1 Prophylaxis and therapy of acquired immunodeficiency syndrome |
03/21/1991 | CA2025684A1 Antibodies and proteins |
03/21/1991 | CA2025263A1 Complex suitable for carrying out a method of purifying pre-s hepatitis b surface antigen |
03/20/1991 | EP0418014A1 Tumor necrosis factor-alpha and -beta receptors |
03/20/1991 | EP0417906A1 Expression of a functional insect specific toxin gene in mammalian cells |
03/20/1991 | EP0417870A2 Chelates for complexation of radioactive isotopes, their metal complexes and their use in diagnosis and therapy |
03/20/1991 | EP0417819A1 Psycho-pharmacological peptides |
03/20/1991 | EP0417743A1 Cleavage promoter |
03/20/1991 | EP0417721A2 Novel peptidase and isomerase inhibitors |
03/20/1991 | EP0417619A1 High molecular protein-fatty acid condensates with excellent skin and mucus membrane compatibility |
03/20/1991 | EP0417563A2 TNF-binding proteins |
03/20/1991 | EP0417541A2 Process of preparing a protein-oriented membrane |
03/20/1991 | EP0417524A1 Antigens and polypeptides derived from babesia (12D3 antigen) |
03/20/1991 | EP0417454A2 Reduced size LHRH analogs |
03/20/1991 | EP0417298A1 Detection of human tissue factor activator |
03/20/1991 | EP0417271A1 Diagnosis and treatment of insulin dependent diabetes mellitus |
03/20/1991 | EP0417217A1 Peptides with sulphate ester groups |
03/20/1991 | EP0417196A1 Immunogenic human interleukin-3 peptide and monoclonal antibodies thereto |
03/20/1991 | EP0417188A1 Protein crosslinking reagents cleavable within acidified intracellular vesicles |
03/20/1991 | EP0417168A1 Antibodies to human mammary cell growth inhibitor and methods of production and use |
03/20/1991 | EP0417165A1 Polypeptide compounds having growth hormone releasing activity. |
03/20/1991 | EP0172865B1 Dna sequences, recombinant dna and processes for producing antigens of plasmodium falciparum |
03/20/1991 | CN1050043A Method for activating protein c |
03/20/1991 | CA2025634A1 Peptides including ctl epitopes of hiv proteins and use thereof |
03/20/1991 | CA2025481A1 Vaccine for aids and hepatitis b |
03/19/1991 | US5001230 T cell activation markers |
03/19/1991 | US5001225 Monoclonal antibodies to a pan-malarial antigen |
03/19/1991 | US5001223 Parathyroid hormone antagonists with enhanced metabolic properties |